Comparison of Respiratory Symptoms and Pulmonary Functions of Adult Male Cigarette Smokers and Non-smokers in Sri Lanka; A Comparative Analytical Study

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2025 Feb 12

PMID 39937707

Authors

Prasanna Herath

Savithri Wasundara Wimalasekera

Thamara Dilhani Amarasekara

Manoj Sanjeewa Fernando

Sue Turale

Affiliations

Soon will be listed here.

Abstract

Background: Cigarette smoking has long been associated with decreased lung function and increased respiratory symptoms globally. While this relationship is well-established, a critical gap exists in our understanding of the specific impact of smoking intensity on individual lung volumes, particularly among the general population. Despite numerous studies conducted on this topic worldwide, there is a noticeable absence of research focusing on the Sri Lankan population, and South Asian studies in this context remain sparse. This study evaluated the prevalence of respiratory symptoms and pulmonary function changes among chronic cigarette smokers and compared them with non-smokers. Furthermore, the proposed study intends to close this gap by undertaking a systematic assessment of the influence of cigarette smoking on lung function and respiratory symptoms in the general population of Sri Lanka. Additionally, the present research represents the first-ever Lung function study conducted in Sri Lanka specifically targeting cigarette smokers.

Methods: Adult male daily smokers (n = 360) and matched non-smokers (n = 180) from the Colombo district, Sri Lanka, were chosen. Smokers were compared in age, height, and weight with a matched nonsmoking control group. An interviewer provided a questionnaire to collect data on socio-demographic information, smoking behaviors, and clinical respiratory symptoms. Lung function tests were performed with a calibrated PC-based Medikro® Pro (Finland) spirometer and forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), and FEV1/ FVC ratio, peak expiratory flow (PEF), forced expiratory flow between 25% and 75% of FVC (FEF 25-75%) were measured.

Results: Smokers had a significantly higher prevalence of respiratory symptoms and significantly lower FVC, FEV1, FEV1/ FVC, and PEF, FEF 25-75% values than non-smokers. There was a significantly negative correlation of FVC, FEV1, FEV1/ FVC, and PEF, FEF 25-75% with the duration of smoking, and the Brinkman Index. According to the Multiple regression analysis, smoking significantly contributed to deteriorated pulmonary function variables.

Conclusion: This study revealed that continuous smoking accelerates the deterioration of lung function and increases respiratory symptoms. Early strategies to reduce tobacco use are recommended.

References

Sansores R, Velazquez-Uncal M, Perez-Bautista O, Villalba-Caloca J, Falfan-Valencia R, Ramirez-Venegas A . Prevalence of chronic obstructive pulmonary disease in asymptomatic smokers. Int J Chron Obstruct Pulmon Dis. 2015; 10:2357-63. PMC: 4636090. DOI: 10.2147/COPD.S91742. View

Asharani P, Ai Ling Seet V, Abdin E, Siva Kumar F, Wang P, Roystonn K . Smoking and Mental Illness: Prevalence, Patterns and Correlates of Smoking and Smoking Cessation among Psychiatric Patients. Int J Environ Res Public Health. 2020; 17(15). PMC: 7432787. DOI: 10.3390/ijerph17155571. View

Cheung K, Fung T, Mak J, Cheung S, He W, Leung J . The acute effects of cigarette smoke exposure on muscle fiber type dynamics in rats. PLoS One. 2020; 15(5):e0233523. PMC: 7239437. DOI: 10.1371/journal.pone.0233523. View

Gogou E, Kotsiou O, Siachpazidou D, Pinaka M, Varsamas C, Bardaka F . Underestimation of respiratory symptoms by smokers: a thorn in chronic obstructive pulmonary disease diagnosis. NPJ Prim Care Respir Med. 2021; 31(1):14. PMC: 7955112. DOI: 10.1038/s41533-021-00226-y. View

Cooper B . An update on contraindications for lung function testing. Thorax. 2010; 66(8):714-23. DOI: 10.1136/thx.2010.139881. View

Church D, Pryor W . Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect. 1985; 64:111-26. PMC: 1568603. DOI: 10.1289/ehp.8564111. View

Culver B, Graham B, Coates A, Wanger J, Berry C, Clarke P . Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement. Am J Respir Crit Care Med. 2017; 196(11):1463-1472. DOI: 10.1164/rccm.201710-1981ST. View

Yang S . [Relationship between smoking habits and lung function changes with conventional spirometry]. J Formos Med Assoc. 1993; 92 Suppl 4:S225-31. View

DOLL R, Peto R, Boreham J, Sutherland I . Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer. 2005; 92(3):426-9. PMC: 2362086. DOI: 10.1038/sj.bjc.6602359. View

10.

Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J . Developing COPD: a 25 year follow up study of the general population. Thorax. 2006; 61(11):935-9. PMC: 2121175. DOI: 10.1136/thx.2006.062802. View

11.

Bird Y, Staines-Orozco H . Pulmonary effects of active smoking and secondhand smoke exposure among adolescent students in Juárez, Mexico. Int J Chron Obstruct Pulmon Dis. 2016; 11:1459-67. PMC: 4934558. DOI: 10.2147/COPD.S102999. View

12.

Jenkins B, Sarpong D, Addison C, White M, Hickson D, White W . Joint effects of smoking and sedentary lifestyle on lung function in African Americans: the Jackson Heart Study cohort. Int J Environ Res Public Health. 2014; 11(2):1500-19. PMC: 3945550. DOI: 10.3390/ijerph110201500. View

13.

Wu X, Zhu B, Xu S, Bi Y, Liu Y, Shi J . A cross country comparison for the burden of cardiovascular disease attributable to tobacco exposure in China, Japan, USA and world. BMC Public Health. 2020; 20(1):888. PMC: 7282071. DOI: 10.1186/s12889-020-09031-7. View

14.

Andreas S, Hering T, Muhlig S, Nowak D, Raupach T, Worth H . Smoking cessation in chronic obstructive pulmonary disease: an effective medical intervention. Dtsch Arztebl Int. 2009; 106(16):276-82. PMC: 2689574. DOI: 10.3238/arztebl.2009.0276. View

15.

Boulet L, Lemiere C, Archambault F, Carrier G, Descary M, Deschesnes F . Smoking and asthma: clinical and radiologic features, lung function, and airway inflammation. Chest. 2006; 129(3):661-8. DOI: 10.1378/chest.129.3.661. View

16.

Urrutia I, Capelastegui A, Quintana J, Muniozguren N, Basagana X, Sunyer J . Smoking habit, respiratory symptoms and lung function in young adults. Eur J Public Health. 2005; 15(2):160-5. DOI: 10.1093/eurpub/cki113. View

17.

Chowdhury N, Nessa A, Begum M, Nabi M, Matin N . Relationship between Pack Year and Lung Function Parameters in Asymptomatic Smokers. Mymensingh Med J. 2021; 30(2):509-513. View

18.

Tantisuwat A, Thaveeratitham P . Effects of smoking on chest expansion, lung function, and respiratory muscle strength of youths. J Phys Ther Sci. 2014; 26(2):167-70. PMC: 3944281. DOI: 10.1589/jpts.26.167. View

19.

Cai Y, Xu W, Liu H, Wang F, Duan L, Li H . Effects of cigarette smoking on older chinese men treated with clopidogrel monotherapy or aspirin monotherapy: a prospective study. Platelets. 2019; 31(5):667-673. DOI: 10.1080/09537104.2019.1667494. View

20.

Mee-Inta A, Tamornpark R, Yeemard F, Upala P, Apidechkul T . Pulmonary function and factors associated with current smoking among the hill tribe populations in northern Thailand: a cross-sectional study. BMC Public Health. 2020; 20(1):1725. PMC: 7670626. DOI: 10.1186/s12889-020-09857-1. View